About Us
Industry Aerospace & Defence Autolus is a private biopharmaceutical company based in West London. Our work is focused on the development and commercialisation of engineered T-cell immunotherapy products for the safe treatment of cancer patients. The Company’s ultimate aim is to be an industry leader in the field of medicines whereby life-threatening diseases are treated by a patient’s own cells Autolus is at an exciting stage of development as we prepare for regulatory approval and commercial launch of our transformative Leukaemia product.